Skip to main content
. 2017 Dec 15;9(3):3379–3393. doi: 10.18632/oncotarget.23273

Figure 2. Leukemia free and overall survival in patients receiving a myeloablative regimen.

Figure 2

The probabilities of leukemia-free and overall survival by conditioning regimen (TBF-MAC vs BF-MAC).